Evofem Biosciences (EVFM) SEC Filings & 10K Form

$0.01
0.00 (0.00%)
(As of 05/3/2024 ET)

Recent Evofem Biosciences SEC Filings

DateFilerForm TypeView
05/02/2024
4:28 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:36 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:40 AM
Evofem Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
4:14 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:14 PM
CVI Investments, Inc. (Filed by)
Evofem Biosciences (Subject)
Form SC 13G/A
02/01/2024
8:05 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:26 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
4:13 PM
Evofem Biosciences (Issuer)
Zhang Yan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:53 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:05 PM
Evofem Biosciences (Issuer)
Kamdar Kim P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:17 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2023
6:40 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
6:57 PM
Evofem Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
09/27/2023
7:50 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
3:49 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
7:01 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
11:15 PM
Evofem Biosciences (Filer)
Form EFFECT
08/14/2023
4:24 PM
Evofem Biosciences (Filer)
Form 424B3
08/14/2023
4:25 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
4:26 PM
Evofem Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
4:29 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
4:31 PM
Evofem Biosciences (Filer)
Form S-1/A
07/17/2023
3:05 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
4:16 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
7:00 PM
Evofem Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/01/2023
7:36 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2023
4:13 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:EVFM) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners